You are here

Allergan

Lilly, Amgen and more back advocacy group's push to double migraine research dollars

Lilly, Amgen and more back advocacy group's push to double migraine research dollars

Fierce Pharma

Teva Pharmaceutical

Flag link:

AbbVie dumps unwanted Sosei neuro pact from Allergan's past

AbbVie dumps unwanted Sosei neuro pact from Allergan's past

Fierce Biotech

Flag link:

Aji Bio-Pharma and Revance in manufacturing deal for anti-wrinkle rival to Botox

Aji Bio-Pharma and Revance in manufacturing deal for anti-wrinkle rival to Botox

Biopharma Reporter

drug manufacturing

daxiabotulinumtoxinA

Flag link:

AbbVie's Botox wins reprieve as agency bars Evolus' Jeaveau for alleged trade-secrets theft

AbbVie's Botox wins reprieve as agency bars Evolus' Jeaveau for alleged trade-secrets theft

Fierce Pharma

Flag link:

AbbVie chases its next golden goose for a post-Humira future with new ulcerative colitis data for Rinvoq

AbbVie chases its next golden goose for a post-Humira future with new ulcerative colitis data for Rinvoq

Endpoints

Flag link:

Unmet Need in Dry Eye Disease Market Leaves Room for Other Drugmakers to Step In

Unmet Need in Dry Eye Disease Market Leaves Room for Other Drugmakers to Step In

BioSpace

dry eye disease

Kala Pharmaceuticals

Flag link:

Former Allergan program posts positive topline PhIII results in farsightedness in an R&D win post-AbbVie merger

Former Allergan program posts positive topline PhIII results in farsightedness in an R&D win post-AbbVie merger

Endpoints

clinical trials

Flag link:

AbbVie’s Allergan Aesthetics brand gets a facelift

AbbVie’s Allergan Aesthetics brand gets a facelift

Fierce Pharma

Flag link:

Its sale to Allergan was called off at the last minute. One year later, a biotech co-founded by Henri Termeer finds a new buyer

Its sale to Allergan was called off at the last minute. One year later, a biotech co-founded by Henri Termeer finds a new buyer

Endpoints

Lysosomal Therapeutics

Flag link:

Vesper Healthcare Acquisition, a SPAC led by the former CEO of Allergan, files for a $400 million IPO

Vesper Healthcare Acquisition, a SPAC led by the former CEO of Allergan, files for a $400 million IPO

NASDAQ

Vesper Healthcare Acquisition

Flag link:

AbbVie & UroGen Overactive Bladder Treatment Misses in Phase 2 Trial

AbbVie & UroGen Overactive Bladder Treatment Misses in Phase 2 Trial

Xconomy

overactive bladder

Flag link:

AbbVie cuts Editas CRISPR pact it inherited from Allergan

AbbVie cuts Editas CRISPR pact it inherited from Allergan

Fierce Biotech

Editas Medicine

Flag link:

AbbVie draws first blood in trade secrets war between Allergan's Botox and Evolus

AbbVie draws first blood in trade secrets war between Allergan's Botox and Evolus

Fierce Pharma

Daewoong Pharmaceuticals

Flag link:

FDA rejects AbbVie's eye drug, citing safety concerns

FDA rejects AbbVie's eye drug, citing safety concerns

BioPharma Dive

Molecular Partners

wet age-related macular degeneration

Flag link:

Allergan ex-CEO Saunders takes board seat at BridgeBio

Allergan ex-CEO Saunders takes board seat at BridgeBio

Fierce Biotech

Flag link:

Amid Allergan buyout, AbbVie dumps unwanted Assembly microbiome pact

Amid Allergan buyout, AbbVie dumps unwanted Assembly microbiome pact

Fierce Biotech

Assembly Biosciences

Flag link:

Abbvie-Allergan complete, but critics continue to raise anti-competitive concerns

Abbvie-Allergan complete, but critics continue to raise anti-competitive concerns

Endpoints

Flag link:

Breast Implant Makers Land in Hot Water with FDA

Breast Implant Makers Land in Hot Water with FDA

Medical Devices and Diagnostics Industry

breast implants

Flag link:

Small biotech Oyster Point sets up pitch to disrupt dry eye market with nasal spray

Small biotech Oyster Point sets up pitch to disrupt dry eye market with nasal spray

Endpoints

Oyster Point Pharma

dry eye disease

Flag link:

AbbVie, Allergan score FTC approval for $63B merger with one final hurdle left to go

AbbVie, Allergan score FTC approval for $63B merger with one final hurdle left to go

Fierce Pharma

Flag link:

Pages